Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 14, 2021. Long positions only.
- Positions
- 37
- No 13F data for Q4 2020
- Portfolio value
- $122.1M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 600,000 | $15.1M | 12.3% | – | – | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 38,350 | $8.24M | 6.7% | – | – | History |
| EHCEncompass Health Corp | COM | 100,000 | $8.19M | 6.7% | – | – | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 105,828 | $7.34M | 6.0% | – | – | History |
| CUECue Biopharma, Inc. | COM | 556,777 | $6.79M | 5.6% | – | – | History |
| BMYBristol Myers Squibb Co | Stock | 95,600 | $6.04M | 4.9% | – | – | History |
| ALBOAlbireo Pharma, Inc. | COM | 170,352 | $6.00M | 4.9% | – | – | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 473,446 | $5.63M | 4.6% | – | – | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 66,419 | $5.12M | 4.2% | – | – | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 360,834 | $4.68M | 3.8% | – | – | History |
| KZRKezar Life Sciences, Inc. | COM | 750,310 | $4.47M | 3.7% | – | – | History |
| MGTXMeiraGTx Holdings plc | COM | 291,944 | $4.21M | 3.4% | – | – | History |
| ZGNXZogenix, Inc. | COM NEW | 195,000 | $3.81M | 3.1% | – | – | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 21,197 | $3.39M | 2.8% | – | – | History |
| PRQRProQR Therapeutics N.V. | SHS EURO | 450,165 | $2.98M | 2.4% | – | – | History |
| OSCROscar Health, Inc. | CL A | 107,086 | $2.88M | 2.4% | – | – | History |
| CLLSCellectis S.A. | SPON ADS | 137,900 | $2.79M | 2.3% | – | – | History |
| INOVInovalon Holdings, Inc. | COM CL A | 85,000 | $2.45M | 2.0% | – | – | History |
| MDTMedtronic plc | Stock | 20,088 | $2.37M | 1.9% | – | – | History |
| UNHUnitedHealth Group Inc | Stock | 6,000 | $2.23M | 1.8% | – | – | History |
| TVRDTvardi Therapeutics, Inc. | COM | 100,000 | $2.17M | 1.8% | – | – | History |
| MTCRMetacrine, Inc. | COM | 304,485 | $1.89M | 1.5% | – | – | History |
| SLDBSolid Biosciences Inc. | COM | 320,100 | $1.77M | 1.4% | – | – | History |
| LHCGLHC Group, Inc | COM | 8,783 | $1.68M | 1.4% | – | – | History |
| AKUAkumin Inc. | COM | 429,061 | $1.59M | 1.3% | – | – | History |
| BEAMBeam Therapeutics Inc. | COM | 17,000 | $1.36M | 1.1% | – | – | History |
| ALXNAlexion Pharmaceuticals, Inc. | COM | 8,685 | $1.33M | 1.1% | – | – | History |
| ONCROncorus, Inc. | COM | 70,807 | $986.0K | 0.8% | – | – | History |
| APTOAptose Biosciences Inc. | COM NEW | 150,000 | $896.0K | 0.7% | – | – | History |
| ADMAAdma Biologics, Inc. | COM | 497,842 | $876.0K | 0.7% | – | – | History |
| XCURExicure, Inc. | COM | 275,848 | $601.0K | 0.5% | – | – | History |
| SIOXSio Gene Therapies Inc. | COMMON | 205,900 | $537.0K | 0.4% | – | – | History |
| BAXBaxter International Inc | Stock | 5,800 | $489.0K | 0.4% | – | – | History |
| ODTOdonate Therapeutics, Inc. | COM | 117,621 | $402.0K | 0.3% | – | – | History |
| MORFMorphic Holding, Inc. | COM | 5,202 | $329.0K | 0.3% | – | – | History |
| ORGOOrganogenesis Holdings Inc. | COM | 15,232 | $278.0K | 0.2% | – | – | History |
| ASMBAssembly Biosciences, Inc. | COM | 56,500 | $260.0K | 0.2% | – | – | History |